• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 93 of 100
TechPharma M&A boom rolls on: now Celgene’s buying Receptos
By Geoffrey SmithJuly 15, 2015
TechVida Health and AstraZeneca launch new app for post-heart attack recovery
By Laura LorenzettiJuly 14, 2015
TechMeet BioBot, the ‘MakerBot of biology’
By Andrew ZaleskiJuly 13, 2015
TechNovartis senses a blockbuster after FDA approves its new heart drug
By Geoffrey SmithJuly 9, 2015
RetailCVS Health leaving U.S. Chamber of Commerce over smoking spat
By Phil WahbaJuly 8, 2015
FinanceIreland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
By Tom Huddleston Jr.July 7, 2015
186815051
TechDespite regulatory troubles, DNA testing firm 23andMe raises more money
By Kia KokalitchevaJuly 2, 2015
FeaturesThese are the Coins2Day 500’s fastest-growing pharma companies
By Laura LorenzettiJune 20, 2015
FeaturesThe 10 Biggest Health Care Companies in the Coins2Day 500
By Laura LorenzettiJune 20, 2015
FinanceThese Coins2Day 500 companies leapfrogged the rest
By Kia KokalitchevaJune 19, 2015
Flibanserin
FeaturesA female Viagra is one step closer to reality
By Laura LorenzettiJune 4, 2015
Food and Farm Livestock Antibiotics
RetailAntibiotics in meat: A public health controversy that isn’t going away
By Mark KobaJune 3, 2015
Bristol-Myers Squibb R&D headquarters
TechNew cancer drug combo shrinks tumors in 60% of patients – study
By TIME and Coins2Day EditorsJune 1, 2015
Arts & Entertainment19 kids and cancelled: TV shows that got pulled due to controversy
By Daniel BukszpanMay 28, 2015
FinanceCan Gilead keep growing without a big deal?
By Jen WiecznerMay 23, 2015
1...
  • 91
  • 92
  • 93
  • 94
  • 95
...100
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.